Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II.
Harada N
,
Takahashi T
,
Matsumoto M
,
Kinashi T
,
Ohara J
,
Kikuchi Y
,
Koyama N
,
Severinson E
,
Yaoita Y
,
Honjo T
.
Abstract
T-cell-replacing factor (TRF) is a T-cell-derived factor required for terminal differentiation of activated B cells to immunoglobulin-secreting cells. Previous studies have shown that a murine T-cell hybrid (B151K12) produces factor(s) that (i) induce immunoglobulin secretion by the B-cell leukemia line BCL1 and secondary anti-2,4-dinitrophenyl IgG synthesis in vitro by dinitrophenyl-primed B cells (TRF activity) and (ii) cause proliferation of the BCL1 cells [B-cell growth factor II (BCGF-II) activity]. Both activities appear to be associated with the same molecule. Here we report the production of a monoclonal antibody to murine TRF. The monoclonal antibody, designated TB13, strongly inhibited both TRF and BCGF-II activities and absorbed TRF- as well as BCGF-II-active molecules produced by B151K12 and by Xenopus oocytes that had been injected with mRNA transcribed from plasmid pSP6K-mTRF23. Inhibition was linearly dependent on the concentration of both TB13 and TRF. Monoclonal antibody TB13 did not inhibit the activities of B-cell stimulatory factor 1, interleukin 1, interleukin 2, or interleukin 3. TRF activity in dissolved samples of immunoprecipitates obtained with TB13 was recovered after NaDodSO4/PAGE, in the fractions corresponding to a protein band at Mr 46,000. Our results indicate that monoclonal antibody TB13 recognizes a molecule that has both TRF and BCGF-II activities.
Andersson,
T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level.
1980, Pubmed
Andersson,
T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level.
1980,
Pubmed
HUNTER,
Preparation of iodine-131 labelled human growth hormone of high specific activity.
1962,
Pubmed
Hamaoka,
Regulation of B-cell differentiation: interactions of factors and corresponding receptors.
1986,
Pubmed
Harada,
BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
1985,
Pubmed
Hirano,
Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).
1985,
Pubmed
Howard,
B cell growth and differentiation factors.
1984,
Pubmed
Howard,
Identification of a T cell-derived b cell growth factor distinct from interleukin 2.
1982,
Pubmed
Isakson,
T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells.
1982,
Pubmed
Kikuchi,
Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. II. Establishment of a T cell hybrid clone constitutively producing killer-helper factor(s) (KHF) and functional analysis of released KHF.
1986,
Pubmed
Kinashi,
Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II.
,
Pubmed
Kishimoto,
Factors affecting B-cell growth and differentiation.
1985,
Pubmed
Lee,
Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities.
1986,
Pubmed
Leibson,
Role of gamma-interferon in antibody-producing responses.
,
Pubmed
Lowenthal,
Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes.
,
Pubmed
Melchers,
Factors controlling the B-cell cycle.
1986,
Pubmed
Mizel,
Interleukin 1 and T cell activation.
1982,
Pubmed
Nakanishi,
Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis.
1984,
Pubmed
Nakanishi,
Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF).
1983,
Pubmed
Noma,
Cloning of cDNA encoding the murine IgG1 induction factor by a novel strategy using SP6 promoter.
,
Pubmed
,
Xenbase
Ohara,
Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.
,
Pubmed
Paige,
Mediators from cloned T helper cell lines affect immunoglobulin expression by B cells.
1982,
Pubmed
Pike,
Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor.
1982,
Pubmed
Puré,
Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line.
1981,
Pubmed
Schimpl,
Replacement of T-cell function by a T-cell product.
1972,
Pubmed
Swain,
Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays.
1983,
Pubmed
Swain,
Role of BCGFII in the differentiation to antibody secretion normal and tumor B cells.
1985,
Pubmed
Takatsu,
Purification and physicochemical characterization of murine T cell replacing factor (TRF).
1985,
Pubmed
Takatsu,
Antigen-induced T cell-replacing factor (TRF). I. Functional characterization of a TRF-producing helper T cell subset and genetic studies on TRF production.
1980,
Pubmed
Takatsu,
Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF.
1980,
Pubmed
Yoshizaki,
Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.
1982,
Pubmed
Zubler,
Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.
1984,
Pubmed